User banner image
User avatar
  • admin

Posts

CCTV4: 20th China Film Huabiao Awards

BEIJING, April 26, 2025 /PRNewswire/ — The latest data from the National Film Administration have revealed that the box office revenue of the mainland Chinese...

The New DePin: OKZOO’s Environmental AIoT Machine Network Leads New Tech Trend

HO CHI MINH CITY, Vietnam, April 26, 2025 /PRNewswire/ — The “new DePin” (Decentralized Physical Infrastructure Network) trend is arising, as OKZOO’s AIoT devices see explosive...

Petal Ads Hosts “Think Tank 2025” Seminar in Japan to Empower Japanese Companies’ Global Expansion

TOKYO, April 26, 2025 /PRNewswire/ — Petal Ads, Huawei’s leading global mobile advertising platform, today successfully hosted the “Think Tank 2025” seminar in Japan. The...

Celularity Receives Nasdaq Notice Regarding Non-Payment of Nasdaq Fees

FLORHAM PARK, N.J., April 25, 2025 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a cellular and regenerative medicine company, today announced...

Rezolute, Inc. Announces Closing of Underwritten Offering

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage biopharmaceutical company committed to developing novel, transformative...

New Data at AACR Annual Meeting Highlights Use of DecisionDx®-Melanoma to Identify Early-Stage Melanoma Patients at High Risk of Distant Metastasis

FRIENDSWOOD, Texas, April 25, 2025 (GLOBE NEWSWIRE) — Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, will...

Myriad Genetics Highlights MRD Clinical Validity Data at American Association for Cancer Research Annual Meeting

Podium presentation showcases the clinical application of Precise™ MRD SALT LAKE CITY, April 25, 2025 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader...

Prelude Announces Presentations at 2025 AACR Annual Meeting

Preclinical data elucidating the mechanism of action of PRT3789, Prelude’s first-in-class, highly selective SMARCA2 degrader currently in early clinical development Highlights from Prelude’s efforts to...

Concord Medical Files Annual Report on Form 20-F for Fiscal 2024

BEIJING, April 26, 2025 /PRNewswire/ — Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a healthcare provider specialized in cancer treatment,...

Zepp Health Corporation Files 2024 Annual Report on Form 20-F

MILPITAS, Calif., April 26, 2025 /PRNewswire/ — Zepp Health Corporation (“Zepp Health” or the “Company”) (NYSE: ZEPP), a global leader in smart wearables and health...